Cover ImageSALE
市場調查報告書

迅速診斷的全球市場:2018年∼2022年

Global Rapid Diagnostics Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 357370
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
Back to Top
迅速診斷的全球市場:2018年∼2022年 Global Rapid Diagnostics Market 2018-2022
出版日期: 2018年02月09日 內容資訊: 英文 137 Pages
簡介

關於迅速診斷

迅速診斷用產品,用於預備及急救醫療篩檢。這些產品,開發給熟練度低的醫療設施。

Technavio的分析師預測,從2018年到2022年之間,全球迅速診斷市場將以7.56%的年複合成長率成長。

本報告提供全球迅速診斷市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模及預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第7章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 比較:各應用領域
  • 血糖檢驗 - 市場規模與預測
  • 心血管代謝檢驗 - 市場規模與預測
  • 傳染病檢查 - 市場規模與預測
  • 妊娠/妊娠檢驗 - 市場規模與預測
  • 大便潛血試驗 - 市場規模與預測
  • 毒性實驗 - 市場規模與預測
  • 凝固實驗 - 市場規模與預測
  • 市場機會:各應用領域

第8章 客戶形勢

第9章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 醫院、診療所
  • 臨床診斷實驗室
  • 居家醫療

第10章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • OEM的存在感的擴大
  • POC的迅速診斷中數位健康的使用
  • M&A的增加

第14章 業者情勢

  • 概要
  • 創造性破壞
  • 競爭情形

第15章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • Abbott
  • BD
  • bioMerieux
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthcare
  • 其他有力的供應商

第16章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR20723

About Rapid Diagnostics

Rapid diagnostic products are used for preliminary and emergency medical screening. These products are developed for medical facilities with low skilled resources.

Technavio's analysts forecast the global rapid diagnostics market to grow at a CAGR of 7.56% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global rapid diagnostics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the rapid diagnostics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Rapid Diagnostics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • BD
  • bioMerieux
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthcare

Market driver

  • Increasing incidence of chronic and infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • High cost of rapid diagnostic products
  • For a full, detailed list, view our report

Market trend

  • Growing presence of OEMs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Blood glucose testing- Market size and forecast 2017-2022
  • Cardiometabolic testing - Market size and forecast 2017-2022
  • Infectious disease testing - Market size and forecast 2017-2022
  • Pregnancy and fertility testing - Market size and forecast 2017-2022
  • Fecal occult testing - Market size and forecast 2017-2022
  • Toxicology testing - Market size and forecast 2017-2022
  • Coagulation testing - Market size and forecast 2017-2022
  • Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Home care settings

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Rapid diagnostics market in Americas
  • Rapid diagnostics market in EMEA
  • Rapid diagnostics market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Growing presence of OEMs
  • Use of digital health in rapid diagnostics for POC
  • Increasing number of M&A

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BD
  • bioMerieux
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthcare
  • Other prominent vendors

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global IVD market
  • Exhibit 02: Global IVD market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global rapid diagnostics market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global rapid diagnostics market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global rapid diagnostics market - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Application - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: Blood glucose testing by rapid diagnostics- Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Blood glucose testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 22: Cardiometabolic testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Cardiometabolic testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 24: Infectious disease testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Infectious disease testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 26: Pregnancy and fertility testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 27: Pregnancy and fertility testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 28: Fecal occult testing by rapid diagnostics- Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Fecal occult testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 30: Toxicology testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Toxicology testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 32: Coagulation testing by rapid diagnostics- Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Toxicology testing by rapid diagnostics - Year over year growth 2018-2022 (%)
  • Exhibit 34: Market opportunity by application
  • Exhibit 35: Customer landscape
  • Exhibit 36: Global rapid diagnostics market by end-user - Market share 2017 (%)
  • Exhibit 37: Global rapid diagnostics market - Market share by geography 2017-2022 (%)
  • Exhibit 38: Regional comparison
  • Exhibit 39: Rapid diagnostics market in the Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 40: Rapid diagnostics market in the Americas - Year over year growth 2018-2022 (%)
  • Exhibit 41: Top 3 countries in Americas
  • Exhibit 42: Rapid diagnostics market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 43: Rapid diagnostics market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 44: Top 3 countries in EMEA
  • Exhibit 45: Rapid diagnostics market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 46: Rapid diagnostics market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 47: Top 3 countries in APAC
  • Exhibit 48: Market opportunity
  • Exhibit 49: Market impact analysis of M&A
  • Exhibit 50: Vendor landscape
  • Exhibit 51: Landscape disruption
  • Exhibit 52: Vendors covered
  • Exhibit 53: Vendor classification
  • Exhibit 54: Market positioning of vendors
  • Exhibit 55: Abbott overview
  • Exhibit 56: Abbott: Business segments
  • Exhibit 57: Abbott: Organizational developments
  • Exhibit 58: Abbott: Geographic focus
  • Exhibit 59: Abbott: Segment focus
  • Exhibit 60: Abbott: Key offerings
  • Exhibit 61: Abbott: Key customers
  • Exhibit 62: BD overview
  • Exhibit 63: BD - Business segments
  • Exhibit 64: BD - Organizational developments
  • Exhibit 65: BD - Geographic focus
  • Exhibit 66: BD - Segment focus
  • Exhibit 67: BD - Key offerings
  • Exhibit 68: BD - Key customers
  • Exhibit 69: bioMerieux: Overview
  • Exhibit 70: bioMerieux: Business segments
  • Exhibit 71: bioMerieux: Organizational developments
  • Exhibit 72: bioMerieux: Geographic focus
  • Exhibit 73: bioMerieux: Segment focus
  • Exhibit 74: bioMerieux: Key offerings
  • Exhibit 75: bioMerieux: Key customers
  • Exhibit 76: Danaher: Overview
  • Exhibit 77: Danaher: Business segments
  • Exhibit 78: Danaher: Organizational developments
  • Exhibit 79: Danaher: Geographic focus
  • Exhibit 80: Danaher: Segment focus
  • Exhibit 81: Danaher: Key offerings
  • Exhibit 82: Danaher: Key customers
  • Exhibit 83: F. Hoffmann-La Roche overview
  • Exhibit 84: F. Hoffmann-La Roche: Business segments
  • Exhibit 85: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 86: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 87: F. Hoffmann-La Roche: Segment focus
  • Exhibit 88: F. Hoffmann-La Roche: Key offerings
  • Exhibit 89: F. Hoffmann-La Roche: Key customers
  • Exhibit 90: Siemens Healthcare: Overview
  • Exhibit 91: Siemens Healthcare: Business segments
  • Exhibit 92: Siemens Healthcare: Organizational developments
  • Exhibit 93: Siemens Healthcare: Geographic focus
  • Exhibit 94: Siemens Healthcare: Segment focus
  • Exhibit 95: Siemens Healthcare: Key offerings
  • Exhibit 96: Siemens Healthcare: Key customers
Back to Top